心力衰竭相关心源性休克:ISHLT共识会议内容摘要
近年来心源性休克(CS)的认知、风险分层和治疗取得显著进展,但短期死亡率仍高达50%。尽管心衰相关心源性休克(HF-CS)占CS病例的50%以上,近期研究多聚焦于急性心肌梗死相关CS,支持HF-CS标准化临床实践的高质量证据匮乏。定义CS、患者表型、治疗目标和疗法的异质性导致已发表报告难以比较,标准化治疗算法难以统一。国际心肺移植学会(ISHLT)组织共识会议,54名参与者代表全球42个中心,旨在更好地定义、诊断和管理HF-CS;本共识报告总结了会议前半部分关于HF-CS的当代文献综述(第1部分),伴随文件(第2部分)涵盖分组讨论以达成共识。
要点
- HF-CS占所有CS病例的>50%,但近期研究多集中于急性心肌梗死相关CS,高质量证据匮乏。
- 尽管药物和器械治疗改善,CS短期死亡率仍高达50%。
- 定义CS、患者表型、治疗目标和疗法的异质性导致已发表报告难以比较、标准化治疗算法难以统一。
- ISHLT共识会议有54名参与者,代表全球42个中心,旨在更好地定义、诊断和管理HF-CS。
- 本报告总结会议前半部分关于HF-CS的当代文献综述,第2部分涵盖分组讨论以达成共识。
适用人群与场景
- 心衰相关心源性休克(HF-CS)患者,占所有CS病例的>50%。
研究设计与关键结果
- ISHLT组织共识会议,54名参与者(晚期心衰和介入心脏病学家、心胸外科医生、重症监护心脏病学家、重症监护医师、药剂师和 allied health professionals),代表全球42个中心,具有丰富的CS临床和发表经验。
- 会议进行了HF-CS最新进展报告,随后计划分组讨论,试图就CS照护模式、HF-CS患者表现和HF-CS管理策略等问题达成共识。
- 本共识报告总结会议前半部分关于HF-CS的当代文献综述(第1部分),伴随文件(第2部分)涵盖分组讨论以达成共识。
证据类型、等级与局限
- 证据类型:ISHLT共识会议内容摘要(指南/共识)。
- 原文指出支持HF-CS标准化临床实践的高质量证据匮乏;定义CS、患者表型、治疗目标和疗法的异质性导致已发表报告难以比较和标准化治疗算法难以统一。
指南或共识出处
- 国际心肺移植学会(ISHLT)共识会议内容摘要,发表于J Heart Lung Transplant。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「对床旁实践的改变」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
In recent years, there have been significant advancements in the understanding, risk-stratification, and treatment of cardiogenic shock (CS). Despite improved pharmacologic and device-based therapies for CS, short-term mortality remains as high as 50%. Most recent efforts in research have focused on CS related to acute myocardial infarction, even though heart failure related CS (HF-CS) accounts for >50% of CS cases. There is a paucity of high-quality evidence to support standardized clinical practices in approach to HF-CS. In addition, there is an unmet need to identify disease-specific diagnostic and risk-stratification strategies upon admission, which might ultimately guide the choice of therapies, and thereby improve outcomes and optimize resource allocation. The heterogeneity in defining CS, patient phenotypes, treatment goals and therapies has resulted in difficulty comparing published reports and standardized treatment algorithms. An International Society for Heart and Lung Transplantation (ISHLT) consensus conference was organized to better define, diagnose, and manage HF-CS. There were 54 participants (advanced heart failure and interventional cardiologists, cardiothoracic surgeons, critical care cardiologists, intensivists, pharmacists, and allied health professionals), with vast clinical and published experience in CS, representing 42 centers worldwide. State-of-the-art HF-CS presentations occurred with subsequent breakout sessions planned in an attempt to reach consensus on various issues, including but not limited to models of CS care delivery, patient presentations in HF-CS, and strategies in HF-CS management. This consensus report summarizes the contemporary literature review on HF-CS presented in the first half of the conference (part 1), while the accompanying document (part 2) covers the breakout sessions where the previously agreed upon clinical issues were discussed with an aim to get to a consensus.
参考来源
- Kanwar MK, Billia F, Randhawa V, et al. Heart failure related cardiogenic shock: An ISHLT consensus conference content summary. J Heart Lung Transplant. 2023. PMID: 38069920. doi:10.1016/j.healun.2023.09.014
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。